Copyright Reports & Markets. All rights reserved.

Global Genetically Modified Animal Model Market Growth (Status and Outlook) 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Genetically Modified Animal Model Market Size 2017-2028
    • 2.1.2 Genetically Modified Animal Model Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Genetically Modified Animal Model Segment by Type
    • 2.2.1 Rat
    • 2.2.2 Mouse
    • 2.2.3 Zebrafish
  • 2.3 Genetically Modified Animal Model Market Size by Type
    • 2.3.1 Genetically Modified Animal Model Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Genetically Modified Animal Model Market Size Market Share by Type (2017-2022)
  • 2.4 Genetically Modified Animal Model Segment by Application
    • 2.4.1 Drug Discovery
    • 2.4.2 Basic Research
    • 2.4.3 Toxicity Test
    • 2.4.4 Parasitological Study
    • 2.4.5 Hereditary Disease Study
  • 2.5 Genetically Modified Animal Model Market Size by Application
    • 2.5.1 Genetically Modified Animal Model Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Genetically Modified Animal Model Market Size Market Share by Application (2017-2022)

3 Genetically Modified Animal Model Market Size by Player

  • 3.1 Genetically Modified Animal Model Market Size Market Share by Players
    • 3.1.1 Global Genetically Modified Animal Model Revenue by Players (2020-2022)
    • 3.1.2 Global Genetically Modified Animal Model Revenue Market Share by Players (2020-2022)
  • 3.2 Global Genetically Modified Animal Model Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Genetically Modified Animal Model by Regions

  • 4.1 Genetically Modified Animal Model Market Size by Regions (2017-2022)
  • 4.2 Americas Genetically Modified Animal Model Market Size Growth (2017-2022)
  • 4.3 APAC Genetically Modified Animal Model Market Size Growth (2017-2022)
  • 4.4 Europe Genetically Modified Animal Model Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Genetically Modified Animal Model Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Genetically Modified Animal Model Market Size by Country (2017-2022)
  • 5.2 Americas Genetically Modified Animal Model Market Size by Type (2017-2022)
  • 5.3 Americas Genetically Modified Animal Model Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Genetically Modified Animal Model Market Size by Region (2017-2022)
  • 6.2 APAC Genetically Modified Animal Model Market Size by Type (2017-2022)
  • 6.3 APAC Genetically Modified Animal Model Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Genetically Modified Animal Model by Country (2017-2022)
  • 7.2 Europe Genetically Modified Animal Model Market Size by Type (2017-2022)
  • 7.3 Europe Genetically Modified Animal Model Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Genetically Modified Animal Model by Region (2017-2022)
  • 8.2 Middle East & Africa Genetically Modified Animal Model Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Genetically Modified Animal Model Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Genetically Modified Animal Model Market Forecast

  • 10.1 Global Genetically Modified Animal Model Forecast by Regions (2023-2028)
    • 10.1.1 Global Genetically Modified Animal Model Forecast by Regions (2023-2028)
    • 10.1.2 Americas Genetically Modified Animal Model Forecast
    • 10.1.3 APAC Genetically Modified Animal Model Forecast
    • 10.1.4 Europe Genetically Modified Animal Model Forecast
    • 10.1.5 Middle East & Africa Genetically Modified Animal Model Forecast
  • 10.2 Americas Genetically Modified Animal Model Forecast by Country (2023-2028)
    • 10.2.1 United States Genetically Modified Animal Model Market Forecast
    • 10.2.2 Canada Genetically Modified Animal Model Market Forecast
    • 10.2.3 Mexico Genetically Modified Animal Model Market Forecast
    • 10.2.4 Brazil Genetically Modified Animal Model Market Forecast
  • 10.3 APAC Genetically Modified Animal Model Forecast by Region (2023-2028)
    • 10.3.1 China Genetically Modified Animal Model Market Forecast
    • 10.3.2 Japan Genetically Modified Animal Model Market Forecast
    • 10.3.3 Korea Genetically Modified Animal Model Market Forecast
    • 10.3.4 Southeast Asia Genetically Modified Animal Model Market Forecast
    • 10.3.5 India Genetically Modified Animal Model Market Forecast
    • 10.3.6 Australia Genetically Modified Animal Model Market Forecast
  • 10.4 Europe Genetically Modified Animal Model Forecast by Country (2023-2028)
    • 10.4.1 Germany Genetically Modified Animal Model Market Forecast
    • 10.4.2 France Genetically Modified Animal Model Market Forecast
    • 10.4.3 UK Genetically Modified Animal Model Market Forecast
    • 10.4.4 Italy Genetically Modified Animal Model Market Forecast
    • 10.4.5 Russia Genetically Modified Animal Model Market Forecast
  • 10.5 Middle East & Africa Genetically Modified Animal Model Forecast by Region (2023-2028)
    • 10.5.1 Egypt Genetically Modified Animal Model Market Forecast
    • 10.5.2 South Africa Genetically Modified Animal Model Market Forecast
    • 10.5.3 Israel Genetically Modified Animal Model Market Forecast
    • 10.5.4 Turkey Genetically Modified Animal Model Market Forecast
    • 10.5.5 GCC Countries Genetically Modified Animal Model Market Forecast
  • 10.6 Global Genetically Modified Animal Model Forecast by Type (2023-2028)
  • 10.7 Global Genetically Modified Animal Model Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Shanghai Model Organisms Center, Inc.
    • 11.1.1 Shanghai Model Organisms Center, Inc. Company Information
    • 11.1.2 Shanghai Model Organisms Center, Inc. Genetically Modified Animal Model Product Offered
    • 11.1.3 Shanghai Model Organisms Center, Inc. Genetically Modified Animal Model Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Shanghai Model Organisms Center, Inc. Main Business Overview
    • 11.1.5 Shanghai Model Organisms Center, Inc. Latest Developments
  • 11.2 Gem Pharmatech Co., Ltd.
    • 11.2.1 Gem Pharmatech Co., Ltd. Company Information
    • 11.2.2 Gem Pharmatech Co., Ltd. Genetically Modified Animal Model Product Offered
    • 11.2.3 Gem Pharmatech Co., Ltd. Genetically Modified Animal Model Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Gem Pharmatech Co., Ltd. Main Business Overview
    • 11.2.5 Gem Pharmatech Co., Ltd. Latest Developments
  • 11.3 Charles River Laboratories
    • 11.3.1 Charles River Laboratories Company Information
    • 11.3.2 Charles River Laboratories Genetically Modified Animal Model Product Offered
    • 11.3.3 Charles River Laboratories Genetically Modified Animal Model Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Charles River Laboratories Main Business Overview
    • 11.3.5 Charles River Laboratories Latest Developments
  • 11.4 Envigo
    • 11.4.1 Envigo Company Information
    • 11.4.2 Envigo Genetically Modified Animal Model Product Offered
    • 11.4.3 Envigo Genetically Modified Animal Model Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Envigo Main Business Overview
    • 11.4.5 Envigo Latest Developments
  • 11.5 Taconic Biosciences
    • 11.5.1 Taconic Biosciences Company Information
    • 11.5.2 Taconic Biosciences Genetically Modified Animal Model Product Offered
    • 11.5.3 Taconic Biosciences Genetically Modified Animal Model Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Taconic Biosciences Main Business Overview
    • 11.5.5 Taconic Biosciences Latest Developments
  • 11.6 Jackson Laboratory
    • 11.6.1 Jackson Laboratory Company Information
    • 11.6.2 Jackson Laboratory Genetically Modified Animal Model Product Offered
    • 11.6.3 Jackson Laboratory Genetically Modified Animal Model Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Jackson Laboratory Main Business Overview
    • 11.6.5 Jackson Laboratory Latest Developments
  • 11.7 Shanghai SLAC
    • 11.7.1 Shanghai SLAC Company Information
    • 11.7.2 Shanghai SLAC Genetically Modified Animal Model Product Offered
    • 11.7.3 Shanghai SLAC Genetically Modified Animal Model Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Shanghai SLAC Main Business Overview
    • 11.7.5 Shanghai SLAC Latest Developments
  • 11.8 Joinn Laboratories
    • 11.8.1 Joinn Laboratories Company Information
    • 11.8.2 Joinn Laboratories Genetically Modified Animal Model Product Offered
    • 11.8.3 Joinn Laboratories Genetically Modified Animal Model Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Joinn Laboratories Main Business Overview
    • 11.8.5 Joinn Laboratories Latest Developments
  • 11.9 Crown Biosciences
    • 11.9.1 Crown Biosciences Company Information
    • 11.9.2 Crown Biosciences Genetically Modified Animal Model Product Offered
    • 11.9.3 Crown Biosciences Genetically Modified Animal Model Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Crown Biosciences Main Business Overview
    • 11.9.5 Crown Biosciences Latest Developments
  • 11.10 Pharmalegacy
    • 11.10.1 Pharmalegacy Company Information
    • 11.10.2 Pharmalegacy Genetically Modified Animal Model Product Offered
    • 11.10.3 Pharmalegacy Genetically Modified Animal Model Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Pharmalegacy Main Business Overview
    • 11.10.5 Pharmalegacy Latest Developments
  • 11.11 Syngene International
    • 11.11.1 Syngene International Company Information
    • 11.11.2 Syngene International Genetically Modified Animal Model Product Offered
    • 11.11.3 Syngene International Genetically Modified Animal Model Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Syngene International Main Business Overview
    • 11.11.5 Syngene International Latest Developments
  • 11.12 Janvier Labs
    • 11.12.1 Janvier Labs Company Information
    • 11.12.2 Janvier Labs Genetically Modified Animal Model Product Offered
    • 11.12.3 Janvier Labs Genetically Modified Animal Model Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 Janvier Labs Main Business Overview
    • 11.12.5 Janvier Labs Latest Developments
  • 11.13 GenOway
    • 11.13.1 GenOway Company Information
    • 11.13.2 GenOway Genetically Modified Animal Model Product Offered
    • 11.13.3 GenOway Genetically Modified Animal Model Revenue, Gross Margin and Market Share (2020-2022)
    • 11.13.4 GenOway Main Business Overview
    • 11.13.5 GenOway Latest Developments
  • 11.14 Psychogenics
    • 11.14.1 Psychogenics Company Information
    • 11.14.2 Psychogenics Genetically Modified Animal Model Product Offered
    • 11.14.3 Psychogenics Genetically Modified Animal Model Revenue, Gross Margin and Market Share (2020-2022)
    • 11.14.4 Psychogenics Main Business Overview
    • 11.14.5 Psychogenics Latest Developments
  • 11.15 Horizon Discovery Group
    • 11.15.1 Horizon Discovery Group Company Information
    • 11.15.2 Horizon Discovery Group Genetically Modified Animal Model Product Offered
    • 11.15.3 Horizon Discovery Group Genetically Modified Animal Model Revenue, Gross Margin and Market Share (2020-2022)
    • 11.15.4 Horizon Discovery Group Main Business Overview
    • 11.15.5 Horizon Discovery Group Latest Developments
  • 11.16 Vitalstar Biotechnology
    • 11.16.1 Vitalstar Biotechnology Company Information
    • 11.16.2 Vitalstar Biotechnology Genetically Modified Animal Model Product Offered
    • 11.16.3 Vitalstar Biotechnology Genetically Modified Animal Model Revenue, Gross Margin and Market Share (2020-2022)
    • 11.16.4 Vitalstar Biotechnology Main Business Overview
    • 11.16.5 Vitalstar Biotechnology Latest Developments

12 Research Findings and Conclusion

The global market for Genetically Modified Animal Model is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Genetically Modified Animal Model market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Genetically Modified Animal Model market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Genetically Modified Animal Model market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Genetically Modified Animal Model market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Genetically Modified Animal Model players cover Shanghai Model Organisms Center, Inc., Gem Pharmatech Co., Ltd., Charles River Laboratories, Envigo and Taconic Biosciences, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Genetically Modified Animal Model market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Genetically Modified Animal Model market, with both quantitative and qualitative data, to help readers understand how the Genetically Modified Animal Model market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Genetically Modified Animal Model market and forecasts the market size by Type (Rat, Mouse and Zebrafish), by Application (Drug Discovery, Basic Research, Toxicity Test and Parasitological Study), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Rat
Mouse
Zebrafish

Segmentation by application
Drug Discovery
Basic Research
Toxicity Test
Parasitological Study
Hereditary Disease Study

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Shanghai Model Organisms Center, Inc.
Gem Pharmatech Co., Ltd.
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Shanghai SLAC
Joinn Laboratories
Crown Biosciences
Pharmalegacy
Syngene International
Janvier Labs
GenOway
Psychogenics
Horizon Discovery Group
Vitalstar Biotechnology

Chapter Introduction
Chapter 1: Scope of Genetically Modified Animal Model, Research Methodology, etc.
Chapter 2: Executive Summary, global Genetically Modified Animal Model market size and CAGR, Genetically Modified Animal Model market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Genetically Modified Animal Model revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Genetically Modified Animal Model revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Genetically Modified Animal Model market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Shanghai Model Organisms Center, Inc., Gem Pharmatech Co., Ltd., Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, Shanghai SLAC, Joinn Laboratories and Crown Biosciences, etc.
Chapter 14: Research Findings and Conclusion

Buy now